Intra-/inter-laboratory validation study on reactive oxygen species assay for chemical photosafety evaluation using two different solar simulators

Toxicology in Vitro

Volumn 28, Issue 4, 2014, Pages 515-523

  Onoue, Satomi ^a   Hosoi, Kazuhiro ^b   Toda, Tsuguto ^c   Takagi, Hironori ^d   Osaki, Naoto ^d   Matsumoto, Yasuhiro ^e   Kawakami, Satoru ^f   Wakuri, Shinobu ^g   Iwase, Yumiko ^h   Yamamoto, Toshinobu ^h   Nakamura, Kazuichi ^c   Ohno, Yasuo ⁱ   Kojima, Hajime ⁱ  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b SANTEN PHARMACEUTICAL CO LTD   (Japan)

^c SHIONOGI AND CO LTD   (Japan)

^d TAISHO PHARMACEUTICAL CO LTD   (Japan)

^e Grelan Pharmaceutical Co Ltd   (Japan)

^f ASAHI KASEI PHARMA CORPORATION   (Japan)

^g HATANO RESEARCH INSTITUTE   (Japan)

^h MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

ⁱ NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Inter laboratory precision; Photoreactivity; Phototoxicity; Reactive oxygen species; Validation

Indexed keywords

PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE;

3T3 CELL LINE; ANIMAL; BIOASSAY; CHEMISTRY; LABORATORY; METABOLISM; MOUSE; PHOTOCHEMISTRY; PROCEDURES; REPRODUCIBILITY; STANDARDS; SUNLIGHT; ULTRAVIOLET RADIATION;

3T3 CELLS; ANIMALS; BIOLOGICAL ASSAY; LABORATORIES; MICE; PHOTOCHEMISTRY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; REPRODUCIBILITY OF RESULTS; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 84893710665     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.11.014     Document Type: Article

References (29)

1. Brendler-Schwaab S., Czich A., Epe B., Gocke E., Kaina B., Muller L., Pollet D., Utesch D. Photochemical genotoxicity: principles and test methods. Report of a GUM task force. Mutat. Res. 2004, 566:65-91.
2. Durbize E., Vigan M., Puzenat E., Girardin P., Adessi B., Desprez P.H., Humbert P.H., Laurent R., Aubin F. Spectrum of cross-photosensitization in 18 consecutive patients with contact photoallergy to ketoprofen: associated photoallergies to non-benzophenone-containing molecules. Contact Dermatitis 2003, 48:144-149.
3. The European Agency for the Evaluation of Medicinal Products, Evaluation of Medicines for Human Use, Committee for Proprietary Medicinal Products (EMEA/CPMP), 2002. Note for Guidance on Photosafety Testing, CPMP/SWP/398/01.
4. Epstein J.H. Phototoxicity and photoallergy in man. J. Am. Acad. Dermatol. 1983, 8:141-147.
5. Epstein J.H., Wintroub B.U. Photosensitivity due to drugs. Drugs 1985, 30:42-57.
6. FDA/CDER, 2002. Guidance for Industry, Photosafety Testing. The Food and Drug Administration, Center for Drug Evaluation and Research.
7. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), 2013. ICH Guideline S10 Guidance on Photosafety Evaluation of Pharmaceuticals (draft).
8. Moore D.E. Mechanisms of photosensitization by phototoxic drugs. Mutat. Res. 1998, 422:165-173.
9. Moore D.E. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf. 2002, 25:345-372.
10. Motley R.J., Reynolds A.J. Photocontact dermatitis due to isopropyl and butyl methoxy dibenzoylmethanes (Eusolex 8020 and Parsol 1789). Contact Dermatitis 1989, 21:109-110.
11. The Organisation for Economic Co-operation and Development (OECD), 2004. OECD Guideline for Testing of Chemicals, 432, In vitro 3T3 NRU Phototoxicity Test.
12. Onoue S., Tsuda Y. Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances. Pharm. Res. 2006, 23:156-164.
13. Onoue S., Igarashi N., Yamada S., Tsuda Y. High-throughput reactive oxygen species (ROS) assay: An enabling technology for screening the phototoxic potential of pharmaceutical substances. J. Pharm. Biomed. Anal. 2008, 46:187-193.
14. Onoue S., Kawamura K., Igarashi N., Zhou Y., Fujikawa M., Yamada H., Tsuda Y., Seto Y., Yamada S. Reactive oxygen species assay-based risk assessment of drug-induced phototoxicity: classification criteria and application to drug candidates. J. Pharm. Biomed. Anal. 2008, 47:967-972.
15. Onoue S., Yamauchi Y., Kojima T., Igarashi N., Tsuda Y. Analytical studies on photochemical behavior of phototoxic substances; effect of detergent additives on singlet oxygen generation. Pharm. Res. 2008, 25:861-868.
16. Onoue S., Ochi M., Gandy G., Seto Y., Igarashi N., Yamauchi Y., Yamada S. High-throughput screening system for identifying phototoxic potential of drug candidates based on derivatives of reactive oxygen metabolites. Pharm. Res. 2010, 27:1610-1619.
17. Onoue S., Hosoi K., Wakuri S., Iwase Y., Yamamoto T., Matsuoka N., Nakamura K., Toda T., Takagi H., Osaki N., Matsumoto Y., Kawakami S., Seto Y., Kato M., Yamada S., Ohno Y., Kojima H. Establishment and intra-/inter-laboratory validation of a standard protocol of reactive oxygen species assay for chemical photosafety evaluation. J. Appl. Toxicol. 2013, 33:1241-1250.
18. Onoue S., Kato M., Yamada S. Development of albuminous reactive oxygen species assay for photosafety evaluation under experimental biomimetic conditions. J. Appl. Toxicol. 2014, 34:158-165.
19. Peters B., Holzhutter H.G. In vitro phototoxicity testing: development and validation of a new concentration response analysis software and biostatistical analyses related to the use of various prediction models. ATLA 2002, 30:415-432.
20. Portes P., Pygmalion M.J., Popovic E., Cottin M., Mariani M. Use of human reconstituted epidermis Episkin for assessment of weak phototoxic potential of chemical compounds. Photodermatol. Photoimmunol. Photomed. 2002, 18:96-102.
21. Seto Y., Hosoi K., Takagi H., Nakamura K., Kojima H., Yamada S., Onoue S. Exploratory and regulatory assessments on photosafety of new drug entities. Curr. Drug Saf. 2012, 7:140-148.
22. Seto Y., Kato M., Yamada S., Onoue S. Development of micellar reactive oxygen species assay for photosafety evaluation of poorly water-soluble chemicals. Toxicol. In Vitro 2013, 27:1838-1846.
23. Spielmann H. In vitro phototoxicity testing. The report and recommendations of ECVAM Workshop 2. ATLA 1994, 22:314-348.
24. Spielmann H., Balls M., Brand M., Doring B., Holzhutter H.G., Kalweit S., Klecak G., Eplattenier H.L., Liebsch M., Lovell W.W., Maurer T., Moldenhauer F., Moore L., Pape W.J., Pfanenbecker U., Potthast J., De Silva O., Steiling W., Willshaw A. EEC/COLIPA project on in vitro phototoxicity testing: first results obtained with a Balb/c 3T3 cell phototoxicity assay. Toxicol. In Vitro 1994, 8:793-796.
25. Spielmann H., Liebsch M., Doring B., Moldenhauer F. First results of an EC/COLIPA validation project of in vitro phototoxicity testing methods. Altex 1994, 11:22-31.
26. Spielmann H., Liebsch M., Pape W.J., Balls M., Dupuis J., Klecak G., Lovell W.W., Maurer T., De Silva O., Steiling W. EEC/COLIPA in vitro photoirritancy program: results of the first stage of validation. Curr. Probl. Dermatol. 1995, 23:256-264.
27. Spielmann H., Balls M., Dupuis J. The international EU/COLIPA in vitro phototoxicity validation study: results of phase II (blind trial). Part 1: the 3T3 NRU phototoxicity test. Toxicol. In Vitro 1998, 12:305-327.
28. Spielmann H., Balls M., Dupuis J., Pape W.J., Silva O., Holzhutter H.G., Gerberick F., Liebsch M., Lovell W.W., Pfannenbecker U. A study on UV filter chemicals from Annex VII of Euroepan Union Directive 76/768/EEC, in the in vitro 3T3 NRU phototoxicity test. ATLA 1998, 26:679-708.
29. Trevisi P., Vincenzi C., Chieregato C., Guerra L., Tosti A. Sunscreen sensitization: a three-year study. Dermatology 1994, 189:55-57.